Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

This study is testing whether adding a dietary supplement called 2'-fucosyllactose (2'-FL) — a sugar naturally found in human breast milk — can help maintain remission and support gut health in young patients with Crohn's disease or ulcerative colitis who are already on a biologic medication. **You may be eligible if...** - You are between 11 and 25 years old - You have been diagnosed with Crohn's disease or ulcerative colitis - Your disease is currently in remission (well-controlled) - You are on a stable dose of an anti-TNF biologic medication (adalimumab or infliximab) for at least 12 weeks - You are not currently taking corticosteroids (steroid medications) **You may NOT be eligible if...** - Your disease is currently active (not in remission) - You are taking corticosteroids - You are not currently on one of the specified biologic medications - Your disease activity score does not meet the remission criteria for your age and disease type Talk to your doctor to see if this trial is right for you.